Zobrazeno 1 - 10
of 1 563
pro vyhledávání: '"A. Allahabadia"'
Publikováno v:
Endocrinology, Diabetes & Metabolism Case Reports, Vol 1, Iss 1, Pp 1-6 (2018)
This case report reviews the rare condition of Riedel’s thyroiditis via a patient case. The report highlights the difficulties that one may encounter when managing such a case in regards to patient symptoms, side effects of medications and the rela
Externí odkaz:
https://doaj.org/article/0e7d7d774e7a496a8e633aa1009fdbf8
Publikováno v:
In BJA Education October 2015 15(5):248-252
Publikováno v:
BMJ: British Medical Journal, 2015 Dec 01. 351
Externí odkaz:
https://www.jstor.org/stable/26523629
Autor:
Peter Novodvorsky, Amit Allahabadia
Publikováno v:
Medicine. 49:515-521
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::822dd94a9fb778fe3bb8c7017d16b1ed
https://doi.org/10.1016/j.mpmed.2021.05.014
https://doi.org/10.1016/j.mpmed.2021.05.014
Autor:
Sophie Hambleton, Caroline A Steele, Zainaba Mohamed, John N. S. Matthews, Tim Cheetham, Tim Barratt, Simon H. S. Pearce, Jonathan Prichard, Gillian Watson, Amanda J. Drake, Justin H Davies, Michael Cole, Mario Abinun, Robert D Murray, Nicola Zammitt, Amit Allahabadia, Paul Dimitri, Sonya Carnell
Publikováno v:
Cheetham, T, Cole, M, Abinun, M, Allahabadia, A, Barratt, T, Davies, J H, Dimitri, P, Drake, A, Mohamed, Z, Murray, R D, Steele, C, Zammitt, N, Carnell, S, Prichard, J, Watson, G, Hambleton, S, Matthews, J N S & Pearce, S H S 2021, ' Adjuvant Rituximab – exploratory trial in young people with Graves’ disease ', Journal of Clinical Endocrinology & Metabolism . https://doi.org/10.1210/clinem/dgab763
Context Remission rates in young people with Graves hyperthyroidism are less than 25% after 2 years of thionamide antithyroid drug (ATD). Objective We explored whether rituximab (RTX), a B-lymphocyte–depleting agent, would increase remission rates
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4ed60c648d777841aed9cf4b20677f5
https://doi.org/10.1530/endoabs.77.oc6.1
https://doi.org/10.1530/endoabs.77.oc6.1
Autor:
Cheetham, T.D., Cole, M., Abinun, M., Allahabadia, A., Barratt, T., Davies, J.H., Dimitri, P., Drake, A., Mohamed, Z., Murray, R.D., Steele, C.A., Zammitt, N., Carnell, S., Prichard, J., Watson, G., Hambleton, S., Matthews, J.N.S., Pearce, S.H.S.
Context\ud \ud Remission rates in young people with Graves hyperthyroidism are less than 25% after 2 years of thionamide antithyroid drug (ATD).\ud \ud \ud \ud Objective\ud \ud We explored whether rituximab (RTX), a B-lymphocyte–depleting agent, wo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::5f5189446377d918e8c658469f7395b1
https://eprints.whiterose.ac.uk/184268/1/dgab763.pdf
https://eprints.whiterose.ac.uk/184268/1/dgab763.pdf
Publikováno v:
BMJ: British Medical Journal, 2009 May 01. 338(7703), 1090-1091.
Externí odkaz:
https://www.jstor.org/stable/25671490